JAKi Regulatory Decisions - FDA, EMA, Canada Save

ADD THE FIRST COMMENT

15 November 2022

Dual target blockade may be better than one in SLE

Inhibition of B-cell Activating Factor (BAFF) has revolutionised the treatment of patients with systemic lupus erythematosus. However, outcomes of therapies within the same class (i.e. BAFF-inhibitor) when evaluated in randomised controlled trials have been inconsistent.

ACR Best Abstracts - Day 3 The last day was jammed with important reports and research including the late breaking ab

Tweet Author

RheumNow

Tweet Content

ACR Best Abstracts - Day 3 The last day was jammed with important reports and research including the late breaking abstracts. These were some of our favorites. #ACR22 https://t.co/vUrxBTF3Wj https://t.co/QKpTjyFfxt

Links

https://bit.ly/3g8j9Ry

Which is better for AxSpA? IL-17i or TNFi?

Best of ACR22 in PsA: Day Three

Autoimmunity Following COVID-19 Infection

Medication Adherence intervention in SLE

RT @ericdeinmd: #ACR22 final plenary session 10 week study outcomes of Philly vs Placebo to be reported #rheumpix @Rheum

Tweet Author

ericdeinmd

Tweet Content

#ACR22 final plenary session 10 week study outcomes of Philly vs Placebo to be reported #rheumpix @RheumNow https://t.co/BradH2Ty70

RT @drdavidliew: Can you put a bit of morphine intraarticularly inside an osteoarthritic knee and make it better? Cute

Tweet Author

drdavidliew

Tweet Content

Can you put a bit of morphine intraarticularly inside an osteoarthritic knee and make it better? Cute idea, no bingo. I get that we're chasing better symptomatic solutions, but... Don't do this. ABST1833 #ACR22 @RheumNow https://t.co/pvsGx93eoU

RT @drdavidliew: Erosive OA: have we got anything disease-modifying? Not much right now (read: nothing) Denosumab 60mg

Tweet Author

drdavidliew

Tweet Content

Erosive OA: have we got anything disease-modifying? Not much right now (read: nothing) Denosumab 60mg q3mo for bone remodelling? radiographic change, erosive jt development: real improvement pain, function: zip at 48w, some at 96w? Def worth more study! ABSTL05 #ACR22 @RheumNow https://t.co/Yo9u5BlYYJ

Topics

JAKi Regulatory Decisions - FDA, EMA, Canada Save

ADD THE FIRST COMMENT

Dual target blockade may be better than one in SLE

ACR Best Abstracts - Day 3 The last day was jammed with important reports and research including the late breaking ab

Which is better for AxSpA? IL-17i or TNFi?

Best of ACR22 in PsA: Day Three

Autoimmunity Following COVID-19 Infection

Medication Adherence intervention in SLE

RT @ericdeinmd: #ACR22 final plenary session 10 week study outcomes of Philly vs Placebo to be reported #rheumpix @Rheum

RT @drdavidliew: Can you put a bit of morphine intraarticularly inside an osteoarthritic knee and make it better? Cute

RT @drdavidliew: Erosive OA: have we got anything disease-modifying? Not much right now (read: nothing) Denosumab 60mg

Do you get our email newsletter?